Northwest Biotherapeutics reported 11.67 in PE Price to Earnings for its fiscal quarter ending in September of 2022.





Pe Change Date
AstraZeneca 25.34 4.25 Jun/2026
Bristol-Myers Squibb 16.14 7.06 Jun/2026
Eisai 26.55 9.06 Jun/2026
Merck 32.26 15.74 Jun/2026
Northwest Biotherapeutics 11.67 6.93 Sep/2022
Pfizer 11.48 2.16 Jun/2026
Roche Holding 16.48 0.39 Jun/2026